Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Biden drug cost cap will save seniors about $1,100 a year, AARP study finds

by
August 28, 2024
in Health Care
0
Biden drug cost cap will save seniors about $1,100 a year, AARP study finds

More than a million U.S. seniors will save $1,100 in prescription drug costs every year under a provision in the 2022 Inflation Reduction Act, according to a new report released Wednesday.

The report was conducted by AARP, which lobbied for the passage of the Inflation Reduction Act in 2022.  

Under the provision, out-of-pocket prescription drug costs for Part D of the Medicare program will be capped at $2,000 every year beginning in 2025.  

Before the Inflation Reduction Act, many Medicare Part D enrollees had to pay 5 percent of their prescription drug costs regardless of how much they had already paid. 

Between 3 and 4 million Medicare Part D enrollees are expected to benefit from the out-of-pocket cap every year between 2025 and 2029.  

About 40 percent of Medicare drug plan enrollees — or roughly 1.4 million people — are expected to reach the new out-of-pocket cap between 2025 and 2029.  

And those Medicare recipients will save an average of 56 percent in their prescription drug costs — or around $1,100 — as part of the provision, according to the analysis.  

Roughly 12 percent of Medicare drug plan enrollees — or about 420,000 people — will save more than $3,000 in prescription drug costs.  

“We want every senior in America to know, thanks to the new annual cap which limits their out-of-pocket costs, they will have more money to invest in their families, spend on their broader health needs or simply save to achieve greater financial stability,” said AARP CEO Jo Ann Jenkins.

The new cap will impact Medicare Part D enrollees differently depending on their age, sex and race or ethnicity, the analysis found.  

Almost half of all Part D enrollees who are expected to reach the new out-of-pocket limit next year are between the ages of 75 and 84, and slightly more women will benefit than men.  

A higher share of Part D enrollees who are part of a North American Indigenous group will benefit from the new cap compared to Part D enrollees who are white, Black, Asian or Hispanic, the report also found.  

Previous Post

Loving your pup may be a many splendored thing

Next Post

Pro-abortion ballot initiatives backed by at least half of Republicans in Arizona, Nevada

Next Post
Pro-abortion ballot initiatives backed by at least half of Republicans in Arizona, Nevada

Pro-abortion ballot initiatives backed by at least half of Republicans in Arizona, Nevada

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    Trump demands drugmakers ‘justify’ COVID treatment success

    Trump demands drugmakers ‘justify’ COVID treatment success

    September 1, 2025
    Former CDC directors sound alarm over Kennedy’s agency shake-up

    Former CDC directors sound alarm over Kennedy’s agency shake-up

    September 1, 2025
    Candida auris: Study reveals who is most vulnerable to deadly fungus infection

    Candida auris: Study reveals who is most vulnerable to deadly fungus infection

    September 1, 2025

    Trending

    New Mexico Governor says potential GOP cuts to Medicaid would ‘destroy health care as we know it’

    New Mexico Governor says potential GOP cuts to Medicaid would ‘destroy health care as we know it’

    May 11, 2025
    Would $5K ‘baby bonus’ be enough to boost US birth rate?

    Would $5K ‘baby bonus’ be enough to boost US birth rate?

    April 23, 2025
    Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

    Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

    February 26, 2025
    US surpasses 1,000 measles cases in 2025, second worst year since disease was declared eliminated

    US surpasses 1,000 measles cases in 2025, second worst year since disease was declared eliminated

    May 8, 2025

    Recent News

    Trump demands drugmakers ‘justify’ COVID treatment success

    Trump demands drugmakers ‘justify’ COVID treatment success

    September 1, 2025
    Former CDC directors sound alarm over Kennedy’s agency shake-up

    Former CDC directors sound alarm over Kennedy’s agency shake-up

    September 1, 2025

    Popular News

    • Trump demands drugmakers ‘justify’ COVID treatment success
    • Former CDC directors sound alarm over Kennedy’s agency shake-up

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.